Cellular Biomedicine Group Inc. announced the appointment of Yihong Yao as Chief Scientific Officer. In this new position, Dr. Yao will spearhead the company's overall scientific research programs in the areas of Immuno-Oncology and inflammatory autoimmune diseases and will be responsible for strengthening the company's Immuno-Oncology platforms and clinical trial design and bioinformatics. Yao brings nearly twenty years of experience in the life sciences industry and academia with strong expertise in clinical biomarker discovery and development, strategy and personalized medicine.